FDANews
FDAnews Drug Daily Bulletin

CEPHALON UP; GETS FDA APPROVABLE LETTER ON PAIN MED

July 3, 2006

Cephalon Inc. (CEPH) shares jumped 10% Friday after the drug company said the government wanted more information before approving Cephalon's proposed new treatment for cancer pain. Therapeutics Daily (http://www.therapeuticsdaily.com/news/article.cfm?contentValue=984403&contentType=sentryarticle&channelID=29)